<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Alexander, Lori</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Travison, Thomas G.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Results from the TOM Trial</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2011</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2011-08-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">15-15</style></pages><abstract><style  face="normal" font="default" size="100%">Testosterone supplementation is known to increase muscle mass and strength in healthy older men. The Clinical Meaningfulness of the Changes in Muscle Performance and Physical Function Associated with Testosterone Administration in Older Men with Mobility Limitation [TOM; NCT00240981] trial [Travison TG et al. J Gerontol 2011] found that testosterone administration was associated with patient-important improvements in muscle strength and stair-climbing power.</style></abstract><number><style face="normal" font="default" size="100%">5</style></number><volume><style face="normal" font="default" size="100%">11</style></volume></record></records></xml>